Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Viral Nonstructural Proteins | 7 | 2024 | 53 | 3.090 |
Why?
|
| West Nile virus | 5 | 2024 | 78 | 2.380 |
Why?
|
| Virus Replication | 4 | 2024 | 318 | 0.850 |
Why?
|
| West Nile Fever | 2 | 2024 | 68 | 0.830 |
Why?
|
| Encephalitis Virus, Japanese | 1 | 2020 | 3 | 0.640 |
Why?
|
| Flavivirus | 1 | 2020 | 16 | 0.630 |
Why?
|
| Cross Reactions | 1 | 2020 | 87 | 0.620 |
Why?
|
| Vero Cells | 4 | 2024 | 112 | 0.590 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 306 | 0.530 |
Why?
|
| Computational Biology | 1 | 2016 | 327 | 0.400 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 108 | 0.390 |
Why?
|
| Nucleoside-Triphosphatase | 2 | 2024 | 13 | 0.390 |
Why?
|
| RNA Helicases | 2 | 2024 | 19 | 0.390 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2024 | 25 | 0.380 |
Why?
|
| Serine Endopeptidases | 2 | 2024 | 48 | 0.380 |
Why?
|
| Cytoplasm | 2 | 2024 | 154 | 0.370 |
Why?
|
| Cell Line | 5 | 2024 | 1410 | 0.290 |
Why?
|
| Albendazole | 1 | 2026 | 8 | 0.240 |
Why?
|
| Anthelmintics | 1 | 2026 | 23 | 0.240 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2026 | 64 | 0.240 |
Why?
|
| Strongylida Infections | 1 | 2026 | 29 | 0.230 |
Why?
|
| Angiostrongylus cantonensis | 1 | 2026 | 36 | 0.230 |
Why?
|
| Dengue Virus | 2 | 2020 | 96 | 0.230 |
Why?
|
| Rhizobium | 1 | 2004 | 10 | 0.220 |
Why?
|
| Disease Outbreaks | 1 | 2026 | 175 | 0.220 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2004 | 17 | 0.220 |
Why?
|
| Sigma Factor | 1 | 2004 | 19 | 0.220 |
Why?
|
| Fabaceae | 1 | 2004 | 30 | 0.220 |
Why?
|
| Animals | 7 | 2026 | 16992 | 0.210 |
Why?
|
| Cell Nucleus | 1 | 2024 | 383 | 0.190 |
Why?
|
| Cell Membrane | 1 | 2024 | 403 | 0.180 |
Why?
|
| Endoplasmic Reticulum, Rough | 1 | 2021 | 3 | 0.170 |
Why?
|
| Humans | 10 | 2026 | 43102 | 0.160 |
Why?
|
| Protein Transport | 1 | 2021 | 296 | 0.160 |
Why?
|
| Immunoassay | 1 | 2020 | 74 | 0.150 |
Why?
|
| Monocytes | 2 | 2011 | 277 | 0.150 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 127 | 0.150 |
Why?
|
| Phylogeny | 2 | 2016 | 769 | 0.130 |
Why?
|
| Kava | 2 | 2007 | 6 | 0.130 |
Why?
|
| Sequence Analysis, Protein | 1 | 2016 | 52 | 0.120 |
Why?
|
| Cloning, Molecular | 1 | 2016 | 314 | 0.110 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 115 | 0.110 |
Why?
|
| Plasmids | 1 | 2016 | 244 | 0.110 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2014 | 39 | 0.100 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 307 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 224 | 0.100 |
Why?
|
| Antigen-Antibody Complex | 1 | 2011 | 20 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2014 | 883 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2011 | 57 | 0.090 |
Why?
|
| Phagocytosis | 1 | 2011 | 86 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 83 | 0.090 |
Why?
|
| Mutation | 1 | 2016 | 1177 | 0.080 |
Why?
|
| Cytokines | 2 | 2011 | 678 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 185 | 0.080 |
Why?
|
| Risperidone | 1 | 2008 | 5 | 0.070 |
Why?
|
| Calcium | 1 | 2011 | 491 | 0.070 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2008 | 15 | 0.070 |
Why?
|
| JC Virus | 1 | 2008 | 23 | 0.070 |
Why?
|
| Polyomavirus Infections | 1 | 2008 | 18 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 2011 | 386 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2011 | 329 | 0.070 |
Why?
|
| Neuroglia | 1 | 2008 | 133 | 0.070 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2007 | 9 | 0.070 |
Why?
|
| Macrophages | 1 | 2011 | 529 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 2007 | 54 | 0.070 |
Why?
|
| Beverages | 1 | 2007 | 66 | 0.060 |
Why?
|
| Least-Squares Analysis | 1 | 2006 | 45 | 0.060 |
Why?
|
| Lactones | 1 | 2006 | 23 | 0.060 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2006 | 25 | 0.060 |
Why?
|
| Meningitis | 1 | 2026 | 10 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2026 | 234 | 0.060 |
Why?
|
| Nitrogen Fixation | 1 | 2004 | 1 | 0.060 |
Why?
|
| Alternative Splicing | 1 | 2004 | 94 | 0.050 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2004 | 171 | 0.050 |
Why?
|
| Hawaii | 2 | 2026 | 2011 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 515 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 1542 | 0.040 |
Why?
|
| Middle Aged | 2 | 2026 | 12222 | 0.030 |
Why?
|
| Plant Extracts | 2 | 2007 | 302 | 0.030 |
Why?
|
| Aged | 1 | 2026 | 8214 | 0.020 |
Why?
|
| Adult | 2 | 2026 | 13872 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2011 | 53 | 0.020 |
Why?
|
| Permeability | 1 | 2011 | 67 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 75 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2011 | 61 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 98 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 128 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 462 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2011 | 269 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 652 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2011 | 195 | 0.020 |
Why?
|
| Male | 2 | 2026 | 23409 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 986 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2011 | 1035 | 0.020 |
Why?
|
| Fetus | 1 | 2008 | 101 | 0.020 |
Why?
|
| Cell Survival | 1 | 2011 | 945 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2008 | 113 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2007 | 19 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2007 | 16 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2007 | 27 | 0.020 |
Why?
|
| Bilirubin | 1 | 2007 | 18 | 0.020 |
Why?
|
| Desiccation | 1 | 2006 | 10 | 0.020 |
Why?
|
| Powders | 1 | 2006 | 20 | 0.020 |
Why?
|
| Anti-Anxiety Agents | 1 | 2006 | 19 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 1070 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 465 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 1081 | 0.010 |
Why?
|
| Mice | 1 | 2011 | 6644 | 0.010 |
Why?
|
| Adolescent | 1 | 2007 | 6081 | 0.010 |
Why?
|
| Female | 1 | 2007 | 24698 | 0.000 |
Why?
|